Yongcan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yongcan Liu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Manran Liu
Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
29 shared publications - Xiaojiang Cui
Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA
29 shared publications - Boxuan Wang
Chongqing Medical University 2 Key Laboratory of Clinical Laboratory Medical Diagnostics, Chinese Ministry of Education Chongqing, China
28 shared publications - Chao Chang
Chongqing Medical University 2 Key Laboratory of Clinical Laboratory Medical Diagnostics, Chinese Ministry of Education Chongqing, China
28 shared publications - Chaoqun Deng
Chongqing Medical University 2 Key Laboratory of Clinical Laboratory Medical Diagnostics, Chinese Ministry of Education Chongqing, China
28 shared publications - Die Meng
Chongqing Medical University 2 Key Laboratory of Clinical Laboratory Medical Diagnostics, Chinese Ministry of Education Chongqing, China
28 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
List of primer sequences utilized in the study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
List of primer sequences utilized in the study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
LM3-derived exosome promotes fatty acid synthesis of lung resident-AT2
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
LM3-derived exosome promotes fatty acid synthesis of lung resident-AT2
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 induced COX2 expression in a PA-dependent manner
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 induced COX2 expression in a PA-dependent manner
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 mediates adaptation to palmitic acid of lung metastatic breast cancer cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 mediates adaptation to palmitic acid of lung metastatic breast cancer cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 mediates adaptation to palmitic acid of lung metastatic breast cancer cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 mediates adaptation to palmitic acid of lung metastatic breast cancer cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
Antibodies and regents utilized in the study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
Antibodies and regents utilized in the study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
Lung metastatic breast cancer cells display increased lipid metabolism and growth advantage
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
Lung metastatic breast cancer cells display increased lipid metabolism and growth advantage
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
COX2 promotes PGE2 production, cell survival and growth of lung metastatic breast cancer cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
COX2 promotes PGE2 production, cell survival and growth of lung metastatic breast cancer cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 mediates lung-specific metastasis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
ACSL5 mediates lung-specific metastasis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
Lung metastatic breast cancer cells display increased lipid metabolism and growth advantage
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
Lung metastatic breast cancer cells display increased lipid metabolism and growth advantage